Fig. 2
From: The deficiency of Maged1 attenuates Parkinson's disease progression in mice
Genetic ablation of Maged1 attenuates motor deficits and disease progression induced by MPTP. A Schematic diagram of the experimental design for behavioral tests. B, C Quantitative analyses of motor coordination using the pole test B and rotarod C tasks, n = 7 per group. D, F Quantification of dopamine (D), DOPAC (E), and HVA (F) using HPLC in the striatum, n = 7 per group. Data are shown as means ± SE. *P < 0.05, ***P < 0.001, #P < 0.05, ##P < 0.01